In trading on Wednesday, Langar Global Healthtech ETF (LGHT) shares fell to $8.08, entering oversold territory with a Relative Strength Index (RSI) of 27.3. This contrasts sharply with the S&P 500’s RSI of 66.6, indicating significantly lower momentum for LGHT compared to broader market trends.
The ETF’s performance over the past year shows a 52-week low of $8.08 and a high of $10.665, with the latest trade recorded at $8.09—down approximately 4% for the day. This decline may present potential buying opportunities for investors seeking to capitalize on perceived exhaustion from heavy selling.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
